MTAP (5 -methylthioadenosine phosphorylase) catalyses the reversible phosphorolytic cleavage of methylthioadenosine leading to the production of methylthioribose-1-phosphate and adenine. Deficient MTAP activity has been correlated with human diseases including cirrhosis and hepatocellular carcinoma. In the present study we have investigated the regulation of MTAP by ROS (reactive oxygen species). The results of the present study support the inactivation of MTAP in the liver of bacterial LPS (lipopolysaccharide)-challenged mice as well as in HepG2 cells after exposure to t-butyl hydroperoxide. Cys 211 were disulfide bonded upon hydrogen peroxide exposure. However, this modification is not relevant to the mediation of the loss of MTAP activity as assessed by site-directed mutagenesis. Regulation of MTAP by ROS might participate in the redox regulation of the methionine catabolic pathway in the liver. Reduced MTA (5 -deoxy-5 -methylthioadenosine)-degrading activity may compensate for the deficient production of the precursor S-adenosylmethionine, allowing maintenance of intracellular MTA levels that may be critical to ensure cellular adaptation to physiopathological conditions such as inflammation.
INTRODUCTION
MTA (5 -deoxy-5 -methylthioadenosine) is a sulfur-containing nucleoside that is present in all cell types including prokaryotes, yeast, plants and higher eukaryotes. In mammalian tissues MTA is generated from its precursor, decarboxylated SAM (S-adenosylmethionine), during the synthesis of polyamines spermine and spermidine [1] or, alternatively, from the spontaneous splitting of SAM under physiological conditions [2] . Although MTA has been known for more than a century, its biological importance was first proposed in 1952 [3] . The enzyme-catalysed conversion of MTA into adenine and MTR1P (5-methylthioribose-1-phosphate) provides the first and rate-limiting step in purine and methionine salvage pathways. MTR1P is recycled into methionine and adenine is used to replenish the AMP and ATP pools [3] . Additionally to its central role in cellular metabolism, MTA also participates in the regulation of a wide variety of cellular functions. Intracellular fluctuations in MTA levels could participate in the regulation of proliferative responses [4] , as well as in the modulation of inflammatory responses [5] . These effects might be mediated by its inhibitory effect on polyamine biosynthesis [6] , by its capacity to interfere with key signalling pathways through the inhibition of growth-factor-induced protein tyrosine phosphorylation and cAMP phosphodiesterase [7] , and by the inhibition of protein methylation [3] , a well-known post-translational modification involved in the modulation of cellular signalling and gene expression. Therefore it appears clear that regulation of MTA levels is crucial to preserve cellular homoeostasis. This concept is further reinforced by studies suggesting the therapeutic potential of this natural compound in different diseased conditions [8, 9] .
MTAP (5 -methylthioadenosine phosphorylase; 5 -deoxy-5 -methylthioadenosine:orthophosphate methylthioribosyltransferase; EC 2.4.2.28) catalyses the reversible phosphorolytic cleavage of MTA leading to the production of MTR1P and adenine [10] . After the original description of this enzymatic activity, MTAP has been purified and characterized from different organisms and tissues [11, 12] . Biochemical and structural evidence indicate that mammalian MTAP is a trimer consisting of three identical subunits of 32 kDa [13] that in humans contain 283 amino acid residues. MTAP is abundantly expressed in normal cells and tissues [14] where it accounts for the production of most of the free adenine generated in human cells [15] . In contrast, lack of MTAP activity is frequently observed in tumour cells [16] . The MTAP gene has been mapped to human chromosome 9p21 [14] in a region that is often deleted in tumour cells. In most cases, it appears that the loss of MTAP activity or mRNA is the result of homozygous deletions of the MTAP gene [17] . However alternative mechanisms must also exist since MTAP impairment was detected in lymphoma and melanoma-derived cell lines with an intact MTAP gene [18, 19] . The presence of a CpG island proximal to the transcription start site of the MTAP promoter [18] has recently been reported, suggesting a transcriptional regulation of the gene through a methylation/demethylation mechanism. This notion was confirmed in HCC (hepatocellular carcinoma) cell lines showing down-regulation of MTAP gene expression that could not be attributed to genomic losses or mutations but to promoter hypermethylation [20] . Additionally, it has been found that the transcriptional activation of the human MTAP gene is mediated by the binding of the CCAAT binding factor to a distal CCAAT motif in the promoter [21] . Besides the regulation at the transcriptional level, there is also evidence suggesting modulation of MTAP activity. Phosphorylation of Ser 183 and Thr 188 residues have been recently reported, although the biological transcendence of these modifications must be demonstrated [22] . Oxidation also arises as a mechanism to modulate MTAP activity as suggested by the requirement of the enzyme for thiol-reducing agents and its specific and rapid inactivation by thiol-blocking groups [23] . However, although the implication of cysteine residues in the stabilization of the MTAP protein from hyperthermophilic organisms through the formation of disulfide bridges has been established [24] , the role of specific thiols in the modulation of MTAP activity is less evident.
In the present study we provide data supporting MTAP inactivation in the liver of mice after induction of an inflammatory reaction by administration of LPS (lipopolysaccharide). Reduction of MTAP activity was also demonstrated in MTAP-expressing HepG2 cells after exposure to t-butyl hydroperoxide. Reversible inactivation of MTAP by ROS (reactive oxygen species) occurs by specific oxidation of Cys 136 and Cys 223 to sulfenic acid as illustrated by the loss of sensitivity of mutants in which these residues were substituted by a serine residue. MTAP inactivation by ROS arises then as a specific regulatory mechanism that might be pivotal in cellular adaptation to physiological or pathological conditions, such as inflammation, that involve oxidative stress.
MATERIALS AND METHODS

Animal experiments
Male C57Bl6 mice (mass of 19-21 g) were from Harlan. Studies were approved by the University of Navarra Committee on Animal Care and satisfied National Institutes of Health guidelines for humane treatment of animals. Mice were injected intraperitoneally with 15 mg/kg of endotoxin (Salmonella typhimurium LPS; Sigma) dissolved in sterile, pyrogen-free saline. Liver tissue was removed after 22 h, snap-frozen in liquid nitrogen and stored at − 80
• C until analysis.
SAM, SAH (S-adenosylhomocysteine) and MTA measurements
Liver samples (50 mg) were homogenized in 250 μl of 0.4 M perchloric acid. Homogenates were centrifuged at 10 000 g at 4
• C for 15 min. SAM, SAH and MTA levels were measured in the supernatant by HPLC as described previously [25] . Then, 100 μl aliquots were loaded on to a Bio-Sil ® ODS-5S column equilibrated in 0.01 M ammonium formate and 4 mM heptanesulfonic acid (pH 4.0). MTA was eluted with a linear gradient (25-100 %) acetonitrile in the same buffer. Chromatograms were analysed with the software 32 Karat 5.0 (Beckman Coulter).
Cell transfection
SK-Hep1 cells grown in 60-mm dishes until 70 % confluence were transfected with a pcDNA3.1 HisA plasmid harbouring the complete human MTAP cDNA, or the empty pcDNA3.1 HisA vector. Transfections were carried out using Tfx-1 (Promega) according to the manufacturer instructions, and transfectants were selected in complete medium containing 0.6 mg/ml of G418 sulfate (Geneticin; Invitrogen) as described previously [26] . After two weeks, individual colonies were harvested, and clones were transfected with the empty vector pcDNA3.1 HisA (SK-EV) or the MTAP-expressing construct (SK-WT) were expanded.
MTAP activity in liver cell lines
HepG2 or SK-Hep1 cells (10 6 ) were plated on 60 mm dishes and were incubated with DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (foetal bovine serum), 1 % GPS (gentamicin-penicillin-streptomycin) and 0.6 mg/ml G418. Then, after cell adhesion, cells were incubated overnight with DMEM without methionine and supplemented with 10 % horse serum and 1 % GPS, at 37
• C and 5% CO 2 . Then, after 40 min incubation with the indicated concentration of t-butyl hydroperoxide at 37
• C, 16 μM MTA was added to the culture medium. MTA consumption was determined by measuring the extracellular MTA remaining after different incubation periods as described above.
MTAP cloning and site-directed mutagenesis
Total human resting peripheral blood lymphocyte RNA was isolated using the guanidinium thiocyanate method [27] and was transcribed to cDNA using the Superscript pre-amplification system (Invitrogen). The cDNA was amplified using Taq Long Plus enzyme (Stratagene) and the sense (5 -CTCGAGATCTG-CATGGCCTCTGGCACC-3 ) and antisense (5 -ATGAATTCC-TTAATGTCTTGGTAATAAAAC-3 ) primers, derived from the human MTAP subunit cDNA sequence. The PCR products were purified using the QIAquick Gel Extraction kit (Qiagen) and ligated into the expression vector pCDNA3.1, according to the manufacturer's instructions (Eukaryotic TA cloning Kit Unidirectional; Invitrogen) or into the plasmid pRSETA (Invitrogen), resulting in constructs that include a 5 -sequence coding for six histidine residues and a protease-cleavage site in-frame with the human MTAP-coding region. Cysteine replacement by a serine residue was performed by site-directed mutagenesis with the QuikChange ® site-directed mutagenesis kit (Stratagene) using the primers indicated in Supplementary Table 1 (at http://www.BiochemJ.org/bj/411/bj4110457add.htm). The cloned products and all mutants were confirmed by sequencing the complete MTAP cDNA. Stable transfectants of each MTAP mutant were established in SK-Hep1 cells as described above.
Expression and purification of recombinant MTAP
Recombinant WT (wild-type) and MTAP mutants were expressed in Escherichia coli BL21(DE3) (Invitrogen) as described previously [28] . Cells were homogenized in 100 mM Tris/HCl (pH 8), 0.5 M NaCl with 1 mM benzamidine, 1 mM PMSF and 0.5 mg/ ml lysozyme. After 30 min incubation on ice, cell extracts were obtained by sonication and the cytosolic fraction was separated by ultracentrifugation at 75 000 rev./min (rotor TLA 100.2; Beckman) at 4
• C for 1 h. Recombinant WT and MTAP mutant proteins were purified from the bacterial cytosolic extracts by affinity chromatography on a Ni 2+ -Sepharose column (GE Healthcare) equilibrated in 50 mM Tris/HCl (pH 8), 0.5 M NaCl and 40 mM imidazole. After washing with 10 column volumes of equilibration buffer, elution was performed with a linear gradient from 40 mM to 1 M imidazole in the same buffer. Histagged MTAP proteins eluted from the Ni 2+ column at 250 mM imidazole. Protein purity was always more than 95 % as estimated by SDS/PAGE [29] . MTAP-containing fractions were pooled, desalted with 5 ml HiPrep desalting columns (GE Healthcare) and the protein concentration was determined using the Bio-Rad protein assay kit based on the Bradford assay [30] . The purified protein was then stored at − 80 • C in the presence of 5 mM DTT (dithiothreitol). Enterokinase processing was performed using the Enterokinase Max assay (Invitrogen) according to the manufacturer's protocol.
MTAP activity assays
DTT was removed from the preparation with HiPrep desalting columns equilibrated in 10 mM Tris/HCl (pH 7.4) and 10 mM KCl immediately before use. Two independent procedures were used to measure the activity of purified WT and MTAP mutant proteins. The reaction mixture always contained 1 μM MTAP protein or liver homogenates (400 μg of total protein) in 50 mM phosphate buffer (pH 7.4) and the appropriate concentration of MTA in a final volume of 400 μl. Pre-incubation with 5 mM DTT or different H 2 O 2 concentrations was performed as indicated. The mixture was then incubated at 37
• C for the indicated period of time and the reaction was stopped with perchloric acid to a final concentration of 0.4 M. MTA measurements were performed by HPLC as indicated previously. Alternatively, MTAP activity was determined according to the procedure described by Singh et al. [31] . Conditions were as described above. The reaction was started by the addition of MTA and consumption was followed by the reduction of the absorbance at 275 nm. H 2 O 2 was added when required to the enzyme and the mixture was incubated for 10 min at 37
• C before adding MTA. Time-course assays were performed in the presence of different concentrations of MTA and initial velocity values were obtained in each case from the linear fitting of the MTA variation in the first 3 min of the reaction. V i against MTA concentration plots were fitted to the Michaelis-Menten equation using Kaleidograph 3.5b5.
Quantification of free thiol groups and sulfenic derivatives
Purified MTAP was pre-incubated for 5 or 30 min with DTT or the appropriate concentration of H 2 O 2 that were subsequently eliminated with a HiPrep desalting column equilibrated in 50 mM phosphate buffer (pH 7.4). Free thiol groups were quantified by incubation with DTNB [Ellman's reagent; 5,5 -dithiobis-(2-nitrobenzoic acid)] following the absorbance at 412 nm resulting from the liberation of TNB [thiobis-(2-nitrobenzoic acid)] after interaction with sulfhydryl groups. The DTNB reaction was performed in a final volume of 400 μl containing 50 mM phosphate buffer (pH 7.4), 1 mM EDTA, 6 M guanidinium chloride, 25 μM protein and 20 mM DTNB. The amount of accessible sulfhydryl groups was calculated by measuring the TNB released using a molar extinction coefficient of 13600 M −1 · cm −1 [32, 33] . Determination of sulfenic acid from cysteine SH oxidation was performed using two different approaches. In the first method, sulfenic acid was titrated with TNB according to the procedure described by Poole et al. [34] . Protein samples prepared as indicated above were incubated with 20 mM TNB at 25
• C for 30 min. The excess of TNB was then removed with HiPrep desalting columns under the same conditions described above. DTT was added (50 mM) to release the TNB associated to SOH groups that was measured by absorbance at 412 nm. Alternatively, NBD-Cl (4-nitrobenzo-2-oxa-1,3-diazole; 20 mM) was used following the procedure described previously [35] . NBD-Cl was added to protein preparations and the mixture was incubated at 25
• C for 30 min. After elimination of the NBD-Cl excess with HiPrep desalting columns, SH-derived adducts and sulfenic resulting derivatives were measured at 420 and 347 nm respectively.
Size-exclusion chromatography
WT and MTAP mutants were chromatographed in a Superdex-200 HR 10/30 column (GE Healthcare) equilibrated in 50 mM Tris/HCl (pH 7.5). Isocratic elution with the same buffer (0.8 ml/ min) was monitored at 280 nm. The column was calibrated in the same conditions using catalase (232 kDa), BSA (67 kDa), trypsin (21 kDa) and ribonuclease A (13.7 kDa) as standards. Alternatively MTAP was denatured by 2 h incubation with 6 M guanidinium chloride after the indicated treatments. Unfolded proteins were then analysed with the same column equilibrated in 100 mM Tris/HCl (pH 3.0) and 6 M guanidinium chloride.
MS analysis
Samples of MTAP protein (50-100 μg) were incubated with 500 μM H 2 O 2 or 5 mM DTT and subsequently prepared for MALDI-TOF-MS (matrix-assisted laser-desorption ionizationtime-of-flight MS) analysis (MALDI TOF GL-REF mass spectrometer; Waters). After desalting to eliminate excess H 2 O 2 or DTT, free cysteine residues were alkylated by a reaction with 100 mM iodoacetamide for 30 min and the protein was precipitated in chloroform/methanol (4:1). Protein pellets were resuspended in 25 mM ammonium bicarbonate and incubated with 2 μl of 50 μg/μl trypsin (Promega) at 37
• C for 12 h. Alternatively, the protein was dissolved in 10 mM Tris/HCl (pH 7.8), 10 mM calcium chloride and incubated with 2 μl of 25 μg/μl chymotrypsin (Roche) at 25
• C for 12 h. Half of the sample was then reduced with 10 mM DTT at 55
• C for 30 min. The digestion mix was desalted with reversed-phase C18-ZipTip (Millipore). Then 1 μl of the resulting solutions were mixed with an equal volume of CHCA (α-cyano-4-hydroxy-trans-cynnamic acid) in 50 % acetonitrile with 0.1 % TFA (trifluoroacetic acid) and spotted on to a MALDI target plate. The system was calibrated daily with a tryptic digest of ADH (alcohol dehydrogenase), and after analysis nearpoint calibration was performed using corticotrophin [ACTH (adrenocorticotrophic hormone)] as the lock-mass standard. Data processing was performed with Masslynx release 4.0 (Waters) to subtract background noise using polynomial order 10 with 10 % of the data points below this polynomial. Data were also smoothed by one smooth operation (Savitzky Golay) with a window of two channels. MS spectra were processed automatically with MASCOT and then interpreted by manual inspection using Masslynx 4.0 (Waters). The presence of disulfide bridges was analysed using MS-Bridge 4.0.8 from the Protein prospector webpage (http://prospector.ucsf.edu/).
Western blot analysis
Liver tissues and cultured cells were lysed and proteins were extracted as previously described [7] . Equal amounts of protein (20 μg) were resolved using SDS/PAGE (12.5 % gels). Proteins were electrophoretically transferred on to nitrocellulose membranes for 45 min at 120 V. Membranes were probed with a 1:5000 or 1:1000 dilution of anti-MTAP (the gift of Dr D.A. Carson, University of California, San Diego, U.S.A.) or anti-(HO-1) (haem oxygenase 1; Stressgene) antibodies respectively. Antichicken and anti-rabbit IgG peroxidase-conjugated secondary antibodies were used for MTAP and HO-1 assays. Blots were developed by enhanced chemiluminiscence (PerkinElmer). 
RESULTS
Impaired MTA degradation in the liver of LPS-challenged mice
To evaluate MTA metabolism under oxidative stress, SAM, SAH and MTA levels were measured in the liver of LPS-treated mice, a well-known condition inducing a redox imbalance in hepatic cells. As previously shown [36] , the inflammatory reaction associated with LPS administration induced a 50 % reduction of hepatic SAM and SAH. However, the MTA concentration was 2.5-fold higher than that measured in control livers ( Figure 1A) . No change in MTAP protein levels was observed upon LPS administration as assessed by Western blot analysis ( Figure 1B ). In agreement with previous studies [37] , HO-1 expression was increased in response to the oxidative stress associated with the inflammatory reaction ( Figure 1B) . Since MTAP catalyses the only known MTA catabolic reaction, the increase in hepatic MTA levels in LPStreated mice, even when the concentration of the precursor SAM was diminished, suggests impairment in MTAP activity. In order to further support this idea, MTAP activity was measured in liver extracts from control and treated mice and a 65 % inactivation was observed upon LPS administration (1.52 + − 0.02 compared with 0.66 + − 0.08 nmol MTA · min −1 · mg −1 of protein in controls and challenged livers respectively).
ROS-mediated MTAP inactivation in hepatic cells
To investigate the effect of ROS on MTAP activity, HepG2 cells were incubated with t-butyl hydroperoxide and the rate of exogenous MTA consumption was determined. As a negative control the experiment was also performed with SK-Hep1 cells, which we have previously shown to lack MTAP expression [19] (Figure 2B) . In all cases, the culture medium was deprived of methionine to prevent endogenous MTA synthesis and was supplemented with horse serum to avoid extracellular MTA degradation by the MTAP present in the commonly used bovine serum [38] . MTA was efficiently degraded by HepG2 MTAP activity within the first 30 h of incubation. As expected, the levels of MTA in the culture medium remained unchanged in the presence of SK-Hep1 cells. Induction of oxidative stress with t-butyl hydroperoxide significantly reduced the capacity of HepG2 cells to metabolize the supplemented MTA (only 30 % of the initial MTA was degraded under these conditions), probably resulting from the inactivation of the constitutive MTAP (Figure 2A ). The steadystate levels of MTAP protein remained unchanged upon t-butyl hydroperoxide exposure ( Figure 2B ). These results suggest that cellular MTAP is inactivated by ROS.
H 2 O 2 -induced MTAP inactivation
The activity of purified MTAP was measured before and after digestion with enterokinase to determine the effect of the Nterminal tag. Only preparations with more than 95 % purity were used for subsequent experiments. Digestion with enterokinase removed the N-terminal tag and resulted in the expected 32 kDa subunits as assessed by SDS/PAGE. Both tagged and digested enzymes had similar MTA-degrading rates of 57.6 and 398 nmol · min −1 · mg −1 when the assay was performed with 15 and 200 μM MTA respectively (results not shown). Since no apparent change of activity was associated with the N-terminal tag, all the experiments were carried out using the His-tagged recombinant proteins. The putative effect of ROS on MTAP activity was studied by pre-incubation of the enzyme with H 2 O 2 . Independently of whether the protein was processed with enterokinase or not, a 60% decrease of the enzymatic activity was measured after oxidation and the inactivation was reversed when the activity assay was performed in the presence of reducing agents (Supplementary Figure at http://www.BiochemJ.org/bj/411/bj4110457add.htm). (Table 1 and Supplementary Figure 1) . The estimated K m for MTA (approx. 30 μM) remained unchanged upon oxidation (Table 1 and Supplementary Figure 1) , suggesting that the loss of activity might result from impairment of the catalytic mechanism more than from impeded MTA binding to the active site of the enzyme. Therefore these results suggest that H 2 O 2 is a non-competitive inhibitor with an estimated IC 50 of approx. 300 μM.
Identification of target cysteine residues involved in the impairment of MTAP activity by ROS
In order to elucidate the participation of cysteine residues on MTAP inactivation by oxidation and to identify the targeted cysteine residue(s), nine mutant MTAP proteins in which a single cysteine residue was replaced by a serine residue were obtained and their susceptibility to inactivation by H 2 O 2 was analysed. Mutants were expressed and purified from E. coli extracts and the purity of the corresponding proteins was always more than 95 % in all preparations used. Replacement of cysteine by serine had no effect on the enzymatic activity of MTAP mutants. Similarly to the WT enzyme, the activity measured at a saturating concentration of MTA was close to 396 nmol MTA consumed · min −1 · mg −1 in all cases ( Figure 3A ). Incubation with 500 μM H 2 O 2 reduced the activity of WT and mutant proteins to approx. 132 nmol MTA consumed · min −1 · mg −1 with the exception of C136S and C223S MTAP species that remained fully active after oxidation ( Figure 3A) . These results suggest that the oxidation of both Cys 136 and Cys 223 is required to mediate MTAP inactivation. The loss of sensitivity to inactivation by ROS of C136S and C223S mutants was also investigated in hepatic cells. In order to do this, stably transfected SK-Hep1 cells expressing these two MTAP mutants were challenged with 10 μM t-butyl hydroperoxide and the consumption of extracellular MTA was measured after 30 h. MTAP mutant protein levels (as determined by Western blot analysis) and the capacity of MTA degradation by transfected SK-Hep1 cells were similar to those observed in HepG2 cells that express the endogenous enzyme (800-1000 pmol MTA consumed · mg −1 · min −1 ). SK-Hep1 cells expressing either of the two mutants were not sensitive to t-butyl hydroperoxide and their MTA-metabolizing activity remained unchanged after exposure to the oxidant ( Figure 3B) MTAP showed the expected decrease (approx. 60 %) of MTA consumption upon exposure to t-butyl hydroperoxide.
Identification of cysteine-SH oxidation derivatives
To characterize the thiol-oxidation derivatives leading to MTAP inactivation we first measured the number of accessible cysteine residues remaining upon incubation with H 2 O 2 . The protein was oxidized and then denatured in 6 M guanidinium chloride to ensure titration of all free cysteine residues with DTNB. This procedure allowed detection of ten cysteine residues in the reduced protein, which is compatible with the presence of nine cysteine residues in the MTAP sequence and one additional residue provided by the N-terminal tag. Incubation with H 2 O 2 restricted the access of the thiol-reacting reagent to four cysteine residues independently of the time of exposure to the oxidant, suggesting the oxidation of six cysteine residues as was further supported by the recovery of reactivity of all ten cysteine residues with DTT. This evidence indicates oxidation of cysteine residues additionally to those responsible for MTAP inactivation by ROS. MS analyses were then performed on tryptic and chymotryptic digests from reduced and H 2 O 2 -treated MTAP aiming to identify cysteine residues involved in a putative disulfide bonding. Ion assignment from MALDI-TOF spectra allowed more than 60 % coverage of the MTAP sequence in all cases. Interestingly, a 1797.13 Da ion was specifically detected on peptide fingerprints from H 2 O 2 -oxidized MTAP and the presence of this peptide species was prevented when oxidation was reversed with DTT ( Figure 4) . The differential ion might result from the interaction between Cys 145 and Cys 211 leading to the association of the corresponding chymotryptic peptides as suggested by the experimental molecular mass which is 2 Da less than that theoretically predicted from the sequence, in agreement with a disulfide-bridged dipeptide. Since no additional cysteine derivatives were identified, the oxidation state of Cys 136 and Cys 223 , responsible for MTAP inactivation, remained unclear. Oxidation to sulfenic acid was then explored using TNB or, alternatively, NBD-Cl. Control MTAP yielded negative results when incubated with either sulfenic-specific reagents. However, after exposure to H 2 O 2 , sulfenic acids were observed independently of the detection method used and were not detectable if the oxidized and modified enzyme were treated with DTT. TNB reagent allowed titration of two sulfenic groups per MTAP subunit ( Figure 5 
DISCUSSION
The participation of MTA in essential metabolic and signalling pathways suggests that the regulation of MTAP activity might be important in facilitating cellular adaptation to physiological or pathological conditions. The liver parenchyma is one of the normal human tissue types where MTAP gene expression is higher [39] . It has been demonstrated that methionine metabolism must be precisely tuned to maintain normal liver function and that impairment of this pathway correlates with hepatocyte dedifferentiation and proliferation leading to the progression of liver diseases [4, 40] . Consistent with the central role of MTA in the cell, a conservative mechanism based on a co-ordinated regulation of MAT (methionine adenosyltransferase), the enzyme catalysing the synthesis of the precursor SAM, and MTAP might prevent a deleterious MTA decrease in hepatocytes ( Figure 6 ). First, the oxidative stress resulting from mild and transient liver damage inactivates MAT perhaps providing an adaptive response that allows hepatocyte survival [41] . Down-regulation of MAT might be correlated with reversible inactivation of MTAP, as has been shown in the present study, to compensate the impaired SAM synthesis leading to maintenance of cellular MTA. Cellular antioxidant defences might reactivate MAT [42] and MTAP returning methionine catabolism and salvage pathways to their normal steady-state. However, the maintenance of the diseased condition results in a persistent impairment of liver MAT [43] and MTAP [19] gene expression through epigenetic mechanisms. In light of these observations it might by hypothesized that impairment of SAM synthesis might be compensated, at least partially, by inactivation of MTAP leading to maintenance of MTA levels that may be critical for cellular stability. The idea of a co-ordinated regulation of MTA metabolism by the redox state of the cell might be further reinforced by results indicating the inactivation of SAM decarboxylase by reactive species [44] . Interestingly, it has been reported that the hepatic levels of putrescine are increased in murine liver upon treatment with LPS resulting from up-regulation of ornithine decarboxylase. However, the increment of putrescine did not promote a parallel increase in spermidine and spermine ( Figure 6 ) [45] . Our results might explain these observations since MTA, which accumulates in the liver of LPS-treated mice as a result of MTAP inactivation, inhibits spermine and spermidine synthases [1, 6] .
Protein oxidation is a common regulatory mechanism of metabolic and signalling pathways [46] . Native MTAP is a homotrimer with active sites composed entirely of residues of the same subunit with the exception of His 137 and Leu 279 that are provided by the neighbouring monomer [13] . The loss of MTAP activity upon exposure to H 2 O 2 is a reversible process that results from the specific oxidation of cysteine residues 136 and 223 as was demonstrated by using the purified enzyme as well as cellular systems whose MTA consumption capacity was severely impaired after an oxidative challenge. These two cysteine residues are conserved in mammalian MTAPs and in the Drosophila melanogaster orthologue but are not present in other MTAP sequences, explaining the lack of cysteine-mediated redox regulation reported in different archaea species [11] . No structural or functional evidence support a direct participation of cysteine residues in MTA binding or in the catalytic mechanism of MTAP, consistent with our finding that the activity of the enzyme remains as in the WT protein when cysteine residues were replaced by serine. However, specific oxidation of Cys 136 and Cys 223 resulted in a reduced V max while the K m of the enzyme remained unchanged, suggesting that the binding of MTA to the active site of MTAP is not modified in the oxidized form. Interestingly, Cys 223 is located on a flexible loop over the active-site cleft of MTAP connecting β-strand 11 with α-helix 5 and is close to Asp 220 and Asp 222 which participate in the catalytic process and Cys 136 is adjacent to His 137 that integrates the MTA-binding pocket of the neighbouring subunit [13] . Moreover, non-conservative substitution of Cys 223 by tyrosine resulted in an inactive MTAP mutant [47] . Therefore it is tempting to speculate that the oxidation of Cys 136 and Cys 223 might alter the microenvironment of these catalytic residues modifying their chemical reactivity and consequently the activity of the enzyme.
Oxidation of the two cysteine residues is required to promote MTAP inactivation as indicated by the loss of sensitivity of C136S and C233S mutants to inactivation by H 2 O 2 . The idea of a disulfide interaction between these residues arises as a probable explanation to the co-ordinated effect of the two oxidation events on MTAP inactivation. However, the distances separating the corresponding sulphur atoms of Cys 136 and Cys 233 from adjacent subunits are 15.77 Å (1 Å = 0.1 nm) and 35.54 Å in the same MTAP monomer [13] , too far away to allow prediction of their interaction without assuming conformational rearrangements that to our knowledge Figure 2) . This observation may suggest a reversible intersubunit interaction that should involve Cys 136 and Cys 223 since the effect was reversed by reducing agents, and mutants lacking these residues failed to accumulate the putatively cross-linked intermediate. Since no disulfide interactions additional to Cys 145 -S-S-Cys 211 were detected, our observations may be explained alternatively assuming the stabilization of Cys 136 and/or Cys 223 sulfenic derivatives through reaction with residues located in the adjacent monomer leading to the formation of reversible intermediates such as sulfenyl amides [48, 49] . This notion might find further support on the time-dependent reduction of sulfenic content per protein subunit observed after oxidation periods longer than 30 min, suggesting their stabilization to derivatives that were recycled back to reduced thiols with reducing agents (Supplementary Figure 2) . Detailed structural studies are required to demonstrate these hypotheses and to fully elucidate the ROSinduced oxidation intermediates of MTAP. In summary, the results of the present study support the loss of MTAP activity in the liver of LPS-challenged mice as well as in HepG2 cells exposed to t-butyl hydroperoxide. MTAP activity is regulated by mechanisms involving the specific and reversible oxidation of cysteine residues Cys 136 and Cys 233 to sulfenic acid that may be further stabilized to a sulfenyl amide intermediate. Additional oxidation events result in disulfide bonding of Cys 145 and Cys 211 thiols, although this modification has no impact on the enzymatic activity of MTAP. In the liver this regulatory mechanism might provide means to maintain intracellular MTA levels under stress conditions such as those imposed by inflammatory reactions ensuring hepatocyte viability.
